Actively Recruiting
ALZEVIT A Nationwide Digital Cohort for APOE Genotyping and Longitudinal Study of Alzheimers Disease Risk and Prevention
Led by Firalis SA · Updated on 2026-09-02
50000
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting the ALZEVIT study, a large, nationwide, digital observational research project in France focused on Alzheimers disease prevention and early identification. It aims to create a comprehensive registry of Apolipoprotein E APOE genotypes, especially identifying individuals at high genetic risk such as APOE b54 carriers and b54b54 homozygotes. This work supports precision prevention strategies amid emerging treatments most effective in early or preclinical Alzheimers stages and is sponsored by Firalis SA with collaboration from French memory centers. Participants aged 45 and older enroll online, provide electronic consent, and self-collect saliva samples at home using kits for centralized APOE genotyping. The study has two phases Phase A 0-18 months will enroll 50,000 participants to determine national APOE genotype frequencies, create a secure registry, and conduct remote cognitive and risk factor assessments. Phase B 12-24 months includes detailed evaluations of about 2,350 selected participants with clinical exams, MRI scans, cognitive testing, and multi-omics biomarker profiling, performed at memory centers or via telemedicine. Participants provide information on demographics, health history, lifestyle, and complete cognitive questionnaires with periodic online follow-ups. The study measures APOE genotype distribution, the feasibility of large-scale genetic screening, and identifies high-risk individuals while securely tracking data over time. Phase B adds detailed clinical, biomarker, and environmental analyses to better understand Alzheimers progression and risk factors. The study aims to build a national infrastructure to support prevention research, facilitate trial recruitment, and advance personalized approaches to Alzheimers disease.
CONDITIONS
Brief Title
ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness
Research Team
H
Hüseyin FIRAT, MD, PhD, HDR
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here